Qi Yan
Pfizer (United States)(US)
Publications by Year
Research Areas
Pneumonia and Respiratory Infections, Respiratory viral infections research, Vector-borne infectious diseases, Bacterial Infections and Vaccines, Mosquito-borne diseases and control
Most-Cited Works
- → Risk of Pneumococcal Disease in US Adults by Age and Risk Profile(2023)45 cited
- → The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy(2021)23 cited
- → Measurement of Atropisomer Racemization Kinetics Using Segmented Flow Technology(2012)18 cited
- → Multicountry Review of Streptococcus pneumoniae Serotype Distribution Among Adults With Community-Acquired Pneumonia(2023)17 cited
- → Effects of meteorological factors on the incidence of <i>meningococcal</i> meningitis(2017)13 cited
- → Borrelia burgdorferi sensu lato prevalence in Ixodes scapularis from Canada: A thirty-year summary and meta-analysis (1990-2020)(2024)8 cited
- → Incidence and clinical outcomes of pneumonia in persons with down syndrome in the United States(2023)7 cited
- → Characterization of Streptococcus pneumoniae isolates obtained from the middle ear fluid of US children, 2011–2021(2024)5 cited
- → <i>Borrelia Burgdorferi</i> Sensu Lato Prevalence in <i>Ixodes Scapularis</i> from Canada: A Thirty-Year Summary and Meta-Analysis (1990-2020)(2024)
- → P-8. Assessment of 13-valent pneumococcal conjugate vaccine effectiveness among people living with HIV in the United States(2025)